HRCVX
Price
$21.49
Change
+$0.12 (+0.56%)
Updated
Jul 3 closing price
Net Assets
526.06M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

HRCVX vs VVIAX

Header iconHRCVX vs VVIAX Comparison
Open Charts HRCVX vs VVIAXBanner chart's image
Carillon Eagle Growth & Income A
Price$21.49
Change+$0.12 (+0.56%)
VolumeN/A
Net Assets526.06M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
HRCVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HRCVX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRCVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. HRCVX (526M). VVIAX pays higher dividends than HRCVX: VVIAX (2.18) vs HRCVX (1.26). HRCVX was incepted earlier than VVIAX: HRCVX (39 years) vs VVIAX (25 years). HRCVX (0.97) is less costly to investors than VVIAX (0.05). HRCVX is a more actively managed with annual turnover of: 40.00 vs. VVIAX (9.00). HRCVX has a lower initial minimum investment than VVIAX: HRCVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. HRCVX (-0.88). VVIAX return over 5 years is better than : 80.13 vs. HRCVX (18.12).
HRCVXVVIAXHRCVX / VVIAX
Total Expense Ratio0.970.051,940%
Annual Report Gross Expense Ratio0.970.051,940%
Fund Existence39 years25 years-
Gain YTD6.4396.198104%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets526M189B0%
Annual Yield % from dividends1.262.1858%
Returns for 1 year-0.8812.03-7%
Returns for 3 years1.4235.174%
Returns for 5 years18.1280.1323%
Returns for 10 years37.67115.6733%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.